NR 565 Weeks 1–4 Advanced Pharmacology Fundamentals 2026
Chamberlain College
1. When a drug is administered orally, it must pass through the liver before
reaching systemic circulation. This process is known as:
A. The blood-brain barrier
B. First-pass effect
C. Enterohepatic recirculation
D. Systemic bioavailability
Answer: B
Rationale: The first-pass effect refers to the metabolism of a drug by the liver or GI tract
before it reaches systemic circulation, which can significantly reduce the concentration of
the active drug.
2. How many half-lives are generally required for a drug to reach a steady-state
concentration in the body?
A. 1 to 2
B. 12 to 15
C. 7 to 10
D. 4 to 5
Answer: D
Rationale: It typically takes approximately 4 to 5 half-lives for a drug to reach steady state,
where the rate of drug administration equals the rate of drug elimination.
,3. Which parameter is the best indicator of a patient’s renal function for the
purpose of drug dosing?
A. Creatinine clearance (CrCl)
B. Blood urea nitrogen (BUN)
C. Serum creatinine alone
D. Urine output volume
Answer: A
Rationale: Creatinine clearance provides a more accurate estimate of Glomerular
Filtration Rate (GFR) and renal drug elimination capacity than serum creatinine alone,
especially in the elderly.
4. A drug that binds to a receptor and produces a maximal biological response is
referred to as a:
A. Full agonist
B. Competitive antagonist
C. Partial agonist
D. Inverse agonist
Answer: A
Rationale: A full agonist binds to a receptor and mimics the endogenous ligand to produce
the maximum possible effect or response.
5. In the elderly, an increase in body fat percentage leads to which change in the
pharmacokinetics of lipid-soluble drugs?
A. Decreased volume of distribution
B. Increased volume of distribution
C. Increased rate of elimination
D. Decreased half-life
Answer: B
, Rationale: Elderly patients typically have increased body fat, which increases the volume
of distribution for lipophilic drugs, potentially leading to a longer half-life and prolonged
effects.
6. Which cytochrome P450 enzyme is responsible for metabolizing
approximately 50% of all clinically used drugs?
A. CYP2D6
B. CYP1A2
C. CYP2C19
D. CYP3A4
Answer: D
Rationale: CYP3A4 is the most abundant CYP enzyme in the liver and is involved in the
metabolism of roughly half of all prescription drugs.
7. What is the primary mechanism of action of Albuterol in the treatment of
asthma?
A. Stimulation of Beta-2 adrenergic receptors
B. Antagonism of muscarinic receptors
C. Inhibition of leukotriene synthesis
D. Blockade of histamine receptors
Answer: A
Rationale: Albuterol is a Short-Acting Beta-2 Agonist (SABA) that causes bronchodilation
by relaxing smooth muscles in the airway.
8. Which of the following describes the ‘Therapeutic Index’ of a drug?
A. The time required for half of the drug to be eliminated
B. The concentration at which the drug is 100% bioavailable
C. The ratio of the lethal dose to the effective dose
D. The range between the minimum effective concentration and the toxic concentration
Answer: C
Chamberlain College
1. When a drug is administered orally, it must pass through the liver before
reaching systemic circulation. This process is known as:
A. The blood-brain barrier
B. First-pass effect
C. Enterohepatic recirculation
D. Systemic bioavailability
Answer: B
Rationale: The first-pass effect refers to the metabolism of a drug by the liver or GI tract
before it reaches systemic circulation, which can significantly reduce the concentration of
the active drug.
2. How many half-lives are generally required for a drug to reach a steady-state
concentration in the body?
A. 1 to 2
B. 12 to 15
C. 7 to 10
D. 4 to 5
Answer: D
Rationale: It typically takes approximately 4 to 5 half-lives for a drug to reach steady state,
where the rate of drug administration equals the rate of drug elimination.
,3. Which parameter is the best indicator of a patient’s renal function for the
purpose of drug dosing?
A. Creatinine clearance (CrCl)
B. Blood urea nitrogen (BUN)
C. Serum creatinine alone
D. Urine output volume
Answer: A
Rationale: Creatinine clearance provides a more accurate estimate of Glomerular
Filtration Rate (GFR) and renal drug elimination capacity than serum creatinine alone,
especially in the elderly.
4. A drug that binds to a receptor and produces a maximal biological response is
referred to as a:
A. Full agonist
B. Competitive antagonist
C. Partial agonist
D. Inverse agonist
Answer: A
Rationale: A full agonist binds to a receptor and mimics the endogenous ligand to produce
the maximum possible effect or response.
5. In the elderly, an increase in body fat percentage leads to which change in the
pharmacokinetics of lipid-soluble drugs?
A. Decreased volume of distribution
B. Increased volume of distribution
C. Increased rate of elimination
D. Decreased half-life
Answer: B
, Rationale: Elderly patients typically have increased body fat, which increases the volume
of distribution for lipophilic drugs, potentially leading to a longer half-life and prolonged
effects.
6. Which cytochrome P450 enzyme is responsible for metabolizing
approximately 50% of all clinically used drugs?
A. CYP2D6
B. CYP1A2
C. CYP2C19
D. CYP3A4
Answer: D
Rationale: CYP3A4 is the most abundant CYP enzyme in the liver and is involved in the
metabolism of roughly half of all prescription drugs.
7. What is the primary mechanism of action of Albuterol in the treatment of
asthma?
A. Stimulation of Beta-2 adrenergic receptors
B. Antagonism of muscarinic receptors
C. Inhibition of leukotriene synthesis
D. Blockade of histamine receptors
Answer: A
Rationale: Albuterol is a Short-Acting Beta-2 Agonist (SABA) that causes bronchodilation
by relaxing smooth muscles in the airway.
8. Which of the following describes the ‘Therapeutic Index’ of a drug?
A. The time required for half of the drug to be eliminated
B. The concentration at which the drug is 100% bioavailable
C. The ratio of the lethal dose to the effective dose
D. The range between the minimum effective concentration and the toxic concentration
Answer: C
